Stem Cells Used to Treat Secondary Progressive Patients in Clinical Trial – Multiple Sclerosis News Today
Multiple Sclerosis News Today |
Stem Cells Used to Treat Secondary Progressive Patients in Clinical Trial
Multiple Sclerosis News Today A phase 2 clinical study from an international group of research centers compared head-to-head autologous hematopoietic stem cell transplantation (AHSCT) and mitoxantrone in treating patients with secondary progressive or relapsing-remitting multiple … |
